Celemics (331920) | AccidentalOrder

KOSDAQ · 8,380 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

93.7B

Rev (2025)

5.8B

Op Inc (2025)

-3.3B

Net Inc (2025)

-4.0B

PBR

4.07

52W

2K~18K

Celemics operates in the Pharmaceuticals sector.

Legal name: Celemics, Inc.

In fiscal year 2025, Celemics (331920) reported revenue of 5.8 billion KRW, down 14.2% from 6.7 billion KRW a year earlier.

Operating profit was -3.3 billion KRW and net income was -4.0 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 93.7 billion KRW, with a P/B of 4.07.

These figures can be verified in the DART filing (receipt no. 20260323000319).

Year	Rev	Op Inc	Net Inc
2025	5.8B	-3.3B	-4.0B
2024	6.7B	-1.9B	12.3B
2023	6.6B	-5.8B	-3.9B
2022	8.7B	-5.7B	-4.8B
2021	8.1B	-6.0B	-5.2B

4 applicable out of 8 items

Semi-Annual Report (2026.06)

Checks

4 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.2% potential dilution.

Capital Increase: 2 capital-increase filing(s) in the last 180 days. [source]

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: 2 major shareholder change(s) in the last 180 days. [source]

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-14	Semi-Annual Report (2026.06)